• Something wrong with this record ?

Comparison of taurolidine with 4% ethylenediaminetetraacetic acid on antimicrobial lock effectiveness: An experimental study

J. Visek, L. Ryskova, P. Cesakova, J. Stanclova, M. Vajrychova, V. Blaha

. 2025 ; 49 (3) : 373-378. [pub] 20250126

Language English

Document type Journal Article, Comparative Study

Persistent link   https://www.medvik.cz/link/bmc25016284

Grant support
This work was supported by the Cooperatio Program, research area Metabolic Diseases, and MH CZ - DRO (UHHK, 00179906).

BACKGROUND: Antimicrobial lock therapy is recommended for preventing and treating catheter-related bloodstream infections, but different solutions have uncertain efficacy. METHODS: Two locks, 1.35% taurolidine and 4% ethylenediaminetetraacetic acid (EDTA), were tested on Staphylococcus epidermidis, Staphylococcus aureus, methicillin-resistant S. aureus, Pseudomonas aeruginosa, multidrug-resistant P. aeruginosa, vancomycin-resistant Enterococcus faecium, Klebsiella oxytoca (carbapenemase producing), K. pneumoniae (extended-spectrum β-lactamase producing), Candida albicans, and Candida glabrata. Broviac catheter segments were incubated with these organisms and then exposed to various lock solutions. Colony-forming units (CFUs) were counted after 2, 4, and 24 h of incubation. RESULTS: Taurolidine showed a significant decrease in CFUs after 2 h in S. aureus, S. epidermidis, methicillin-resistant S. aureus, vancomycin-resistant E. faecium, P. aeruginosa (both sensitive and multidrug-resistant strains), K. oxytoca, C. albicans, and C. glabrata. After 4 h, significant reductions were noted in S. aureus, S. epidermidis, methicillin-resistant S. aureus, P. aeruginosa, multidrug-resistant P. aeruginosa, K. pneumoniae, K. oxytoca, and C. albicans. Taurolidine was also effective after 24 h, especially against methicillin-resistant S. aureus and multidrug-resistant P. aeruginosa. Four percent EDTA acid showed a significant reduction in CFUs after 2 h in S. aureus, vancomycin-resistant E. faecium, P. aeruginosa, K. oxytoca, C. albicans, and C. glabrata. After 4 h, reductions occurred in P. aeruginosa, multidrug-resistant P. aeruginosa, K. oxytoca, and C. albicans and after 24 h in methicillin-resistant S. aureus, P. aeruginosa, and K. oxytoca. CONCLUSION: Taurolidine is more effective than 4% EDTA acid in eradicating Gram-positive and Gram-negative microorganisms and fungi.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016284
003      
CZ-PrNML
005      
20250731092801.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jpen.2725 $2 doi
035    __
$a (PubMed)39865419
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a x
100    1_
$a Visek, Jakub $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000173017899
245    10
$a Comparison of taurolidine with 4% ethylenediaminetetraacetic acid on antimicrobial lock effectiveness: An experimental study / $c J. Visek, L. Ryskova, P. Cesakova, J. Stanclova, M. Vajrychova, V. Blaha
520    9_
$a BACKGROUND: Antimicrobial lock therapy is recommended for preventing and treating catheter-related bloodstream infections, but different solutions have uncertain efficacy. METHODS: Two locks, 1.35% taurolidine and 4% ethylenediaminetetraacetic acid (EDTA), were tested on Staphylococcus epidermidis, Staphylococcus aureus, methicillin-resistant S. aureus, Pseudomonas aeruginosa, multidrug-resistant P. aeruginosa, vancomycin-resistant Enterococcus faecium, Klebsiella oxytoca (carbapenemase producing), K. pneumoniae (extended-spectrum β-lactamase producing), Candida albicans, and Candida glabrata. Broviac catheter segments were incubated with these organisms and then exposed to various lock solutions. Colony-forming units (CFUs) were counted after 2, 4, and 24 h of incubation. RESULTS: Taurolidine showed a significant decrease in CFUs after 2 h in S. aureus, S. epidermidis, methicillin-resistant S. aureus, vancomycin-resistant E. faecium, P. aeruginosa (both sensitive and multidrug-resistant strains), K. oxytoca, C. albicans, and C. glabrata. After 4 h, significant reductions were noted in S. aureus, S. epidermidis, methicillin-resistant S. aureus, P. aeruginosa, multidrug-resistant P. aeruginosa, K. pneumoniae, K. oxytoca, and C. albicans. Taurolidine was also effective after 24 h, especially against methicillin-resistant S. aureus and multidrug-resistant P. aeruginosa. Four percent EDTA acid showed a significant reduction in CFUs after 2 h in S. aureus, vancomycin-resistant E. faecium, P. aeruginosa, K. oxytoca, C. albicans, and C. glabrata. After 4 h, reductions occurred in P. aeruginosa, multidrug-resistant P. aeruginosa, K. oxytoca, and C. albicans and after 24 h in methicillin-resistant S. aureus, P. aeruginosa, and K. oxytoca. CONCLUSION: Taurolidine is more effective than 4% EDTA acid in eradicating Gram-positive and Gram-negative microorganisms and fungi.
650    12
$a EDTA $x farmakologie $7 D004492
650    12
$a taurin $x analogy a deriváty $x farmakologie $7 D013654
650    12
$a thiadiaziny $x farmakologie $7 D013829
650    12
$a antiinfekční látky $x farmakologie $7 D000890
650    12
$a katétrové infekce $x prevence a kontrola $x mikrobiologie $7 D055499
650    _2
$a Candida albicans $x účinky léků $7 D002176
650    _2
$a lidé $7 D006801
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a počet mikrobiálních kolonií $7 D015169
650    _2
$a Pseudomonas aeruginosa $x účinky léků $7 D011550
650    _2
$a Staphylococcus epidermidis $x účinky léků $7 D013212
650    _2
$a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
650    _2
$a Staphylococcus aureus $x účinky léků $7 D013211
655    _2
$a časopisecké články $7 D016428
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Ryskova, Lenka $u Department of Clinical Microbiology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Cesakova, Petra $u Department of Clinical Microbiology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Stanclova, Jana $u Department of Clinical Microbiology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
700    1_
$a Vajrychova, Marie $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
700    1_
$a Blaha, Vladimir $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Medical Faculty in Hradec Kralove, Charles University in Prague, Hradec Kralove, Czech Republic
773    0_
$w MED00002877 $t JPEN. Journal of parenteral and enteral nutrition $x 1941-2444 $g Roč. 49, č. 3 (2025), s. 373-378
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39865419 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731092756 $b ABA008
999    __
$a ok $b bmc $g 2366852 $s 1253409
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 49 $c 3 $d 373-378 $e 20250126 $i 1941-2444 $m JPEN. Journal of parenteral and enteral nutrition $n JPEN J Parenter Enteral Nutr $x MED00002877
GRA    __
$p This work was supported by the Cooperatio Program, research area Metabolic Diseases, and MH CZ - DRO (UHHK, 00179906).
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Archiving options